Utility of bevacizumab in chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia

被引：0
|
作者：
Gutierrez-Macias, A. [1 ,2 ]
Barroso-Benayos, I. [1 ]
Burzako-Sanchez, A. [1 ]
机构：
[1] Hosp Univ Basurto, Dept Med Interna, Bilbao, Spain
[2] Hosp Univ Basurto, Serv Med Interna, Ave Montevideo 18, Bilbao 48013, Bizkaia, Spain
来源：
REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2023年 / 88卷 / 04期
关键词：
D O I：
10.1016/j.rgmx.2023.04.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：433 / 434
页数：2
相关论文
共 50 条
  • [41] Pazopanib reduces bleeding in hereditary hemorrhagic telangiectasia?
    Faughnan, M. E.
    Gossage, J. R.
    Chakinala, M. M.
    Oh, S. P. S.
    Kasthuri, R.
    Hughes, C. C. W.
    McWilliams, J. P.
    Parambil, J. G.
    Donaldson, J.
    Paul, Gitanjali
    Berry, P.
    Sprecher, D.
    ANGIOGENESIS, 2018, 21 (01) : 119 - 119
  • [42] INTESTINAL BLEEDING IN HEREDITARY HEMORRHAGIC TELANGIECTASIA - REPLY
    WELLING, RE
    SOUTHERN MEDICAL JOURNAL, 1987, 80 (10) : 1331 - 1331
  • [43] The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia
    Ghaheri, Bobak A.
    Fong, Karen J.
    Hwang, Peter H.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2006, 134 (06) : 1006 - 1009
  • [44] Prolonged benefit in hereditary hemorrhagic telangiectasia with bevacizumab maintenance
    Rubin, Jerome
    ANGIOGENESIS, 2015, 18 (04) : 561 - 561
  • [45] An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia
    Al-Samkari, Hanny
    Albitar, Hasan A.
    Olitsky, Scott E.
    Clancy, Marianne S.
    Iyer, Vivek N.
    HAEMOPHILIA, 2020, 26 (06) : 1038 - 1045
  • [46] Injection of bevacizumab and cyanoacrylate glue for hereditary hemorrhagic telangiectasia
    Khoueir, Nadim
    Borsik, Michel
    Camous, Domitille
    Herman, Philippe
    Verillaud, Benjamin
    LARYNGOSCOPE, 2019, 129 (10): : 2210 - 2215
  • [47] Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
    Buscarini, Elisabetta
    Maria Botella, Luisa
    Geisthoff, Urban
    Kjeldsen, Anette D.
    Mager, Hans Jurgen
    Pagella, Fabio
    Suppressa, Patrizia
    Zarrabeitia, Roberto
    Dupuis-Girod, Sophie
    Shovlin, Claire L.
    ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [48] Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia
    Kochanowski, J.
    Sobieszczanska, M.
    Tubek, S.
    Zurek, M.
    Pawelczak, J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (03) : 680 - 681
  • [49] Intermittent bevacizumab therapy experience in hereditary hemorrhagic telangiectasia
    Sahin, O.
    Albayrak, M.
    Yildiz, A.
    Comert, P.
    Ozturk, C.
    Maral, S.
    Ozturk, H. Afacan
    LEUKEMIA RESEARCH, 2018, 73 : S39 - S39
  • [50] Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia
    Azzopardi, Nicolas
    Dupuis-Girod, Sophie
    Ternant, David
    Fargeton, Anne-Emmanuelle
    Ginon, Isabelle
    Faure, Frederic
    Decullier, Evelyne
    Roux, Adeline
    Carette, Marie-France
    Gilbert-Dussardier, Brigitte
    Hatron, Pierre-Yves
    Lacombe, Pascal
    Leguy-Seguin, Vanessa
    Riviere, Sophie
    Corre, Romain
    Bailly, Sabine
    Paintaud, Gilles
    MABS, 2015, 7 (03) : 630 - 637
12345